The study on estazolam with escitalopram make use of limited time and dosage for the treatment of chronic insomnia
LAN Shengzuo
TU Jun
FANG Qiao
LU Dibin
CHEN Xiaozhang
Abstract：Objective:Try to find a more effective treatment and lower relapse rate methods of chronic insomnia. Mehtods:Limited time and dosage combined use of Estazolam and Escitalopram comparison with estazolam alone in treatment of chronic insomnia. AIS Scale and CGI Scale were to assess its efficacy and relapse rate at the time the group,when the withdrawal,with-drawal two weeks. Results:AIS score,the study group was significantly lower(P < 0. 05)than the control group at 30 days after enrollment,very significantly lower(P < 0. 01)than the control group at 45 days after enrollment. Efficacy index(EI). The study group was very significantly lower(P < 0. 01)than the control group at 30 days after enrollment,significantly lower(P <0. 05)than the control group at 45 days after enrollment. Insomnia relapse rate,after 15 days withdrawal,the study group was significantly lower than the control group(P < 0. 05). Conclusion:Limited time and dosage combined use of Estazolam and Es-citalopram. Than single use estazolam treatment of chronic insomnia,more efficient,security,and lower relapse rate.
Keywords：limited time and dosageestazolamescitalopramchronic insomnia
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 803-805 )